Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Nicholas M. Barnes, Gerard P. Ahern, Carine Bécamel, et al.
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 310-520
Open Access | Times Cited: 204

Showing 1-25 of 204 citing articles:

Tryptophan Metabolism and Gut-Brain Homeostasis
William Roth, Kimia Zadeh, Rushi Vekariya, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2973-2973
Open Access | Times Cited: 313
Structural insights into the lipid and ligand regulation of serotonin receptors
Peiyu Xu, Sijie Huang, Huibing Zhang, et al.
Nature (2021) Vol. 592, Iss. 7854, pp. 469-473
Closed Access | Times Cited: 213
Structural basis of ligand recognition at the human MT1 melatonin receptor
Benjamin Stauch, Linda C. Johansson, John D. McCorvy, et al.
Nature (2019) Vol. 569, Iss. 7755, pp. 284-288
Open Access | Times Cited: 169
The Role of Serotonin Neurotransmission in Gastrointestinal Tract and Pharmacotherapy
Tomasz Guzel, Dagmara Mirowska‐Guzel
Molecules (2022) Vol. 27, Iss. 5, pp. 1680-1680
Open Access | Times Cited: 95
The Concise Guide to PHARMACOLOGY 2023/24: Ion channels
S P H Alexander, Alistair Mathie, John A. Peters, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. S2
Open Access | Times Cited: 94
Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
Z. A. Mamieva, Elena Poluektova, В. М. Свистушкин, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 12, pp. 1204-1219
Open Access | Times Cited: 48
Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease
Joachim Neumann, Britt Hofmann, Stefan Dhein, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4765-4765
Open Access | Times Cited: 41
The neurobiology of social play behaviour: Past, present and future
E. J. Marijke Achterberg, Louk J. M. J. Vanderschuren
Neuroscience & Biobehavioral Reviews (2023) Vol. 152, pp. 105319-105319
Open Access | Times Cited: 33
Multiple modulatory roles of serotonin in chronic pain and injury-related anxiety
Shun Hao, Wantong Shi, Weiqi Liu, et al.
Frontiers in Synaptic Neuroscience (2023) Vol. 15
Open Access | Times Cited: 32
Latest updates on the serotonergic system in depression and anxiety
Jianwen Lin, Wenxin Liu, Jing Guan, et al.
Frontiers in Synaptic Neuroscience (2023) Vol. 15
Open Access | Times Cited: 26
Molecular basis of human trace amine-associated receptor 1 activation
Gregory Zilberg, Alexandra Kalia Parpounas, Audrey L. Warren, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents – A Review
Richard A. Glennon, Małgorzata Dukat
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 6, pp. 1722-1745
Open Access | Times Cited: 10
Serotonin Receptor HTR2B Facilitates Colorectal Cancer Metastasis via CREB1–ZEB1 Axis–Mediated Epithelial–Mesenchymal Transition
Tao Li, Lei Wei, Xin Zhang, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 6, pp. 538-554
Closed Access | Times Cited: 9
Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders
Adrian Newman‐Tancredi, Ronan Depoortère, Mark S. Kleven, et al.
Pharmacology & Therapeutics (2021) Vol. 229, pp. 107937-107937
Closed Access | Times Cited: 55
Rewiring of the Serotonin System in Major Depression
Faranak Vahid-Ansari, Paul R. Albert
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 51
Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment
Ansoo Lee, Hyunah Choo, Byungsun Jeon
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6515-6515
Open Access | Times Cited: 30
Current and emerging treatment options for premature ejaculation
Murat Gül, Kadir Böcü, Ege Can Şerefoğlu
Nature Reviews Urology (2022) Vol. 19, Iss. 11, pp. 659-680
Closed Access | Times Cited: 30
A unified hypothesis of SUDEP: Seizure‐induced respiratory depression induced by adenosine may lead to SUDEP but can be prevented by autoresuscitation and other restorative respiratory response mechanisms mediated by the action of serotonin on the periaqueductal gray
Carl L. Faingold, Huajun Feng
Epilepsia (2023) Vol. 64, Iss. 4, pp. 779-796
Closed Access | Times Cited: 22
Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
Alaina M. Jaster, Javier González‐Maeso
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3595-3612
Open Access | Times Cited: 22
Enhancing the Therapeutic Effect in Alzheimer's Disease Drugs: The role of Polypharmacology and Cholinesterase inhibitors
M. Margarida Martins, Paula S. Branco, Luı́sa M. Ferreira
ChemistrySelect (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 19
Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism
Kevin Domanegg, Wolfgang H. Sommer, Marcus W. Meinhardt
Cells (2023) Vol. 12, Iss. 6, pp. 963-963
Open Access | Times Cited: 18
Reduced serotonergic transmission alters sensitivity to cost and reward via 5-HT1A and 5-HT1B receptors in monkeys
Yukiko Hori, Koki Mimura, Yuji Nagai, et al.
PLoS Biology (2024) Vol. 22, Iss. 1, pp. e3002445-e3002445
Open Access | Times Cited: 6
Biased agonism in drug discovery: Is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases?
Kinga Sałaciak, Karolina Pytka
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107872-107872
Open Access | Times Cited: 34
Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota–Gut–Brain Axis
Elena Layunta, Berta Buey, José Emilio Mesonero, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 34
In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5‐HT2AR
Eline Pottie, Christophe P. Stove
Journal of Neurochemistry (2022) Vol. 162, Iss. 1, pp. 39-59
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top